Holen Sie sich die Stockscreener-App
17.92
1.37%
-0.30
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
750.30%
568.44
|
66.85 | 65.82 | 58.11 | 59.78 |
| Nonoperating Income/Loss |
30.70%
2.729
|
3.938 | 13.10 | 2.124 | -0.768 |
| Income/Loss From Continuing Operations Before Tax |
799.19%
-565.71
|
-62.91 | -61.20 | -56.25 | -60.38 |
| Income/Loss From Continuing Operations After Tax |
799.19%
-565.71
|
-62.91 | -61.20 | -56.25 | -60.38 |
Net Income/Loss
|
799.19%
-565.71
|
-62.91 | -61.20 | -56.25 | -60.38 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.61%
742.62
|
738.08 | 6.3735 | 726.66 | 707.90 |
| Diluted Average Shares |
0.61%
742.62
|
738.08 | 6.3735 | 726.66 | 707.90 |
| Basic Earnings Per Share |
744.44%
-0.76
|
-0.09 | -0.09 | -0.08 | -0.09 |
| Diluted Earnings Per Share |
744.44%
-0.76
|
-0.09 | -0.09 | -0.08 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):